vimarsana.com

உருப்படி குறுகிய வடிவம் ஆரோக்கியம் கணக்கெடுப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies

A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial News provided by Share this article Share this article 1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone). 2. PaTHway China Trial is designed to assess the potential of TransCon™ PTH as a hormone replacement therapy, and the aim is to enable patients to have serum calcium (sCa) within the normal range and independence from usual care.

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 | Neurology | JAMA

1. Wiersinga  WJ, Rhodes  A, Cheng  AC, Peacock  SJ, Prescott  HC.  Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review.  2. Wu  Z, McGoogan  JM.  Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.  3. Puntmann  VO, Carerj  ML, Wieters  I,  et al.  Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).  4. Shah  AS, Wong  AW, Hague  CJ,  et al.  A prospective study of 12-week respiratory outcomes in COVID-19–related hospitalisations.  5. Wei  J, Yang  H, L

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial | Lifestyle Behaviors | JAMA

1. Jensen  MD, Ryan  DH, Apovian  CM,  et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society.  2. Heymsfield  SB, van Mierlo  CA, van der Knaap  HC, Heo  M, Frier  HI.  Weight management using a meal replacement strategy: meta and pooling analysis from six studies.  3. Wadden  TA, Foster  GD, Sarwer  DB,  et al.  Dieting and the development of eating disorders in obese women: results of a randomized controlled trial. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.